Skip to main navigation Skip to search Skip to main content

Commentary: Optimizing infliximab therapy for inflammatory bowel disease - The tools are getting sharper

  • Marie France Dubeau
  • , Subrata Ghosh
  • University of Calgary

Research output: Contribution to journalComment/Debate

Original languageEnglish
Pages (from-to)134-136
Number of pages3
JournalGastroenterology and Hepatology
Volume8
Issue number2
Publication statusPublished - Feb 2012
Externally publishedYes

Cite this